查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1596674

脊椎植入物市场：按类型、方法和最终用户划分 - 全球预测 2025-2030

Spinal Allografts Market by Type (Demineralized Bone Matrix, Machined Bones Allograft), Method (Minimally Invasive Spine Surgery, Open Spine Surgery), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年脊椎植入物市场价值为34.5亿美元，预计到2024年将达到37.7亿美元，复合年增长率为9.38%，到2030年预计将达到64.8亿美元。

脊椎移植手术将骨骼和相关组织从捐赠者转移到受体，在脊椎疾病（从退化性椎间盘疾病到创伤和畸​​形）的治疗中发挥重要作用。这些移植物消除了对二次手术部位的需要并减少了患者的恢復时间和不适，从而提供了自体移植物的重要替代方案。脊椎移植物有多种应用，包括脊椎融合手术、肿瘤切除术、椎体重组和畸形矫正术。典型的最终用户包括医院、门诊手术中心和整形外科诊所。脊椎疾病的日益普及、手术技术的进步以及对微创手术的需求不断增加，极大地推动了市场的成长。然而严格的监管要求、高成本以及潜在的移植排斥问题为市场拓展带来了挑战。组织工程、灭菌技术、生物材料与合成材料的整合等方面不断的创新，提供了充足的发展机会。鼓励公司投资专注于增强生物完整性和长期植入稳定性的研究，以吸引骨科医生和医疗保健提供者。透过提高医疗保健专业人员的意识并投资于福利和安全教育，可以加强市场渗透。此外，医疗设备製造商和医疗机构之间的策略联盟和合作促进了创新和市场采用。随着个人化医疗的转变变得更加明显，利用资料分析来客製化脊椎解决方案并投资新型生技药品的研发可以让您在竞争中脱颖而出。脊椎植入物市场是一个充满活力的市场，其特点是技术快速进步和不断发展的法律规范，需要敏捷性和创新来实现持续成长。此类投资不仅可以解决当前的市场限制，还可以释放脊椎护理领域前所未有的成长机会。

主要市场统计
基准年[2023] 34.5亿美元
预测年份 [2024] 37.7亿美元
预测年份 [2030] 64.8亿美元
复合年增长率（%） 9.38%

市场动态：揭示快速发展的脊椎植入物市场的关键市场洞察

供需的动态交互作用正在改变脊椎植入物市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 对微创手术的需求不断增长以及生物材料的进步
    • 脊髓损伤和人口老化加剧
    • 各国医疗基础设施的支持性进展
  • 市场限制因素
    • 与骨移植相关的高成本和不利的报销政策
  • 市场机会
    • 骨头移植术的进展
    • 用于治疗脊椎畸形的脊椎融合手术的出现
  • 市场挑战
    • 缺乏熟练且训练有素的专业人员

波特五力：驾驭脊椎植入物市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解脊椎植入物市场的外部影响

外部宏观环境因素在塑造脊椎植入物市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解脊椎植入物市场的竞争格局

脊椎植入物市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵脊椎植入物市场供应商的绩效评估

FPNV 定位矩阵是评估脊椎植入物市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了脊椎移植物市场的成功之路

脊椎植入物市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对微创手术的需求不断增长以及生物材料的进步
      • 脊髓损伤增加和人口老化
      • 国家医疗基础设施的支持性进步
    • 抑制因素
      • 与骨移植相关的高成本和不利的报销政策
    • 机会
      • 骨移植手术的进展
      • 用于治疗脊椎畸形的脊椎融合手术的出现
    • 任务
      • 缺乏熟练且训练有素的专业人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章脊椎植入物市场：依类型

  • 去矿骨基质
  • 机械加工同种异体骨

第七章脊椎移植物市场：依方法分类

  • 微创脊椎手术
  • 开放性脊椎手术

第八章脊椎植入物市场：依最终用户分类

  • 门诊手术中心
  • 医院

第九章美洲脊椎植入物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区脊椎植入物市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲/中东/非洲脊椎植入物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Alphatec Spine, Inc.
  • Arthrex, Inc.
  • Depuy Synthes, Inc. by Johnson & Johnson Services, Inc.
  • Exactech, Inc.
  • Globus Medical
  • Life Spine, Inc.
  • Medtronic PLC
  • NuVasive, Inc.
  • Nvision Biomedical Technologies, Inc.
  • Orthofix Medical Inc.
  • RTI Surgical, Inc.
  • Stryker Corporation
  • Wright Medical Group NV
  • Xtant Medical Holdings, Inc.
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-03588C870DD6

The Spinal Allografts Market was valued at USD 3.45 billion in 2023, expected to reach USD 3.77 billion in 2024, and is projected to grow at a CAGR of 9.38%, to USD 6.48 billion by 2030.

Spinal allografts, which involve the transplantation of bones or related tissues from a donor to a recipient for spinal surgeries, play a crucial role in treating spinal disorders-ranging from degenerative disc diseases to trauma and deformities. These grafts provide a vital alternative to autografts by eliminating the need for a secondary surgical site, reducing patient recovery time and discomfort. Spinal allografts are utilized in various applications, including spinal fusion, tumor resection, vertebral reconstruction, and correction of deformities. The primary end-users include hospitals, ambulatory surgical centers, and orthopedic clinics. The market's growth is largely propelled by increasing incidence of spinal disorders, advancements in surgical techniques, and rising demand for minimally invasive procedures. However, strict regulatory requirements, high costs, and potential issues of graft rejection pose challenges to market expansion. Continuous innovations in tissue engineering, sterilization techniques, and integration of biological and synthetic materials present ample opportunities for development. Companies are encouraged to invest in research focusing on enhanced biological integration and long-term stability of grafts, to appeal to orthopedic surgeons and healthcare providers. Expanding awareness among healthcare professionals and investing in education regarding benefits and safety can bolster market penetration. Additionally, strategic partnerships and collaborations between medical device manufacturers and healthcare institutions can facilitate innovation and market adoption. With a noticeable shift towards personalized medicine, leveraging data analytics to tailor spinal solutions and investing in R&D for novel biologics can set businesses apart. The spinal allograft market is dynamic, characterized by rapid technological advancements and evolving regulatory frameworks, necessitating agility and innovation for sustained growth. Such investment would not only address current market limitations but also unlock unprecedented opportunities for growth in the field of spinal treatments.

KEY MARKET STATISTICS
Base Year [2023] USD 3.45 billion
Estimated Year [2024] USD 3.77 billion
Forecast Year [2030] USD 6.48 billion
CAGR (%) 9.38%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Spinal Allografts Market

The Spinal Allografts Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing demand for minimally invasive procedures and advancement in biomaterials
    • Increasing instances of spinal cord injuries and the huge aging population
    • Supportive advancements healthcare infrastructure across nations
  • Market Restraints
    • High cost associated with bone graft and unfavorable reimbursement policy
  • Market Opportunities
    • Advancement in the bone grafting procedures
    • Emergence of spinal fusion surgery for the treatment of spinal deformities
  • Market Challenges
    • Dearth of skilled & trained professionals

Porter's Five Forces: A Strategic Tool for Navigating the Spinal Allografts Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Spinal Allografts Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Spinal Allografts Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Spinal Allografts Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Spinal Allografts Market

A detailed market share analysis in the Spinal Allografts Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Spinal Allografts Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Spinal Allografts Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Spinal Allografts Market

A strategic analysis of the Spinal Allografts Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Spinal Allografts Market, highlighting leading vendors and their innovative profiles. These include Alphatec Spine, Inc., Arthrex, Inc., Depuy Synthes, Inc. by Johnson & Johnson Services, Inc., Exactech, Inc., Globus Medical, Life Spine, Inc., Medtronic PLC, NuVasive, Inc., Nvision Biomedical Technologies, Inc., Orthofix Medical Inc., RTI Surgical, Inc., Stryker Corporation, Wright Medical Group N.V., Xtant Medical Holdings, Inc., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Spinal Allografts Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Demineralized Bone Matrix and Machined Bones Allograft.
  • Based on Method, market is studied across Minimally Invasive Spine Surgery and Open Spine Surgery.
  • Based on End-User, market is studied across Ambulatory Surgical Center and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for minimally invasive procedures and advancement in biomaterials
      • 5.1.1.2. Increasing instances of spinal cord injuries and the huge aging population
      • 5.1.1.3. Supportive advancements healthcare infrastructure across nations
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with bone graft and unfavorable reimbursement policy
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancement in the bone grafting procedures
      • 5.1.3.2. Emergence of spinal fusion surgery for the treatment of spinal deformities
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled & trained professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Spinal Allografts Market, by Type

  • 6.1. Introduction
  • 6.2. Demineralized Bone Matrix
  • 6.3. Machined Bones Allograft

7. Spinal Allografts Market, by Method

  • 7.1. Introduction
  • 7.2. Minimally Invasive Spine Surgery
  • 7.3. Open Spine Surgery

8. Spinal Allografts Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Center
  • 8.3. Hospital

9. Americas Spinal Allografts Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Spinal Allografts Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Spinal Allografts Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alphatec Spine, Inc.
  • 2. Arthrex, Inc.
  • 3. Depuy Synthes, Inc. by Johnson & Johnson Services, Inc.
  • 4. Exactech, Inc.
  • 5. Globus Medical
  • 6. Life Spine, Inc.
  • 7. Medtronic PLC
  • 8. NuVasive, Inc.
  • 9. Nvision Biomedical Technologies, Inc.
  • 10. Orthofix Medical Inc.
  • 11. RTI Surgical, Inc.
  • 12. Stryker Corporation
  • 13. Wright Medical Group N.V.
  • 14. Xtant Medical Holdings, Inc.
  • 15. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. SPINAL ALLOGRAFTS MARKET RESEARCH PROCESS
  • FIGURE 2. SPINAL ALLOGRAFTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SPINAL ALLOGRAFTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SPINAL ALLOGRAFTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SPINAL ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SPINAL ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SPINAL ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SPINAL ALLOGRAFTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SPINAL ALLOGRAFTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SPINAL ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SPINAL ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SPINAL ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SPINAL ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SPINAL ALLOGRAFTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SPINAL ALLOGRAFTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SPINAL ALLOGRAFTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SPINAL ALLOGRAFTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SPINAL ALLOGRAFTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SPINAL ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SPINAL ALLOGRAFTS MARKET DYNAMICS
  • TABLE 7. GLOBAL SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SPINAL ALLOGRAFTS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SPINAL ALLOGRAFTS MARKET SIZE, BY MACHINED BONES ALLOGRAFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SPINAL ALLOGRAFTS MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SPINAL ALLOGRAFTS MARKET SIZE, BY OPEN SPINE SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SPINAL ALLOGRAFTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SPINAL ALLOGRAFTS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS SPINAL ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES SPINAL ALLOGRAFTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC SPINAL ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA SPINAL ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM SPINAL ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM SPINAL ALLOGRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM SPINAL ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. SPINAL ALLOGRAFTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 144. SPINAL ALLOGRAFTS MARKET, FPNV POSITIONING MATRIX, 2023